APA (7th ed.) Citation

Williams, B., MacDonald, T. M., Morant, S. V., Webb, D. J., Sever, P., McInnes, G. T., . . . Brown, M. J. (2018). Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: The PATHWAY-2 mechanisms substudies. The lancet. Diabetes & endocrinology, 6(6), 464. https://doi.org/10.1016/S2213-8587(18)30071-8

Chicago Style (17th ed.) Citation

Williams, Bryan, et al. "Endocrine and Haemodynamic Changes in Resistant Hypertension, and Blood Pressure Responses to Spironolactone or Amiloride: The PATHWAY-2 Mechanisms Substudies." The Lancet. Diabetes & Endocrinology 6, no. 6 (2018): 464. https://doi.org/10.1016/S2213-8587(18)30071-8.

MLA (9th ed.) Citation

Williams, Bryan, et al. "Endocrine and Haemodynamic Changes in Resistant Hypertension, and Blood Pressure Responses to Spironolactone or Amiloride: The PATHWAY-2 Mechanisms Substudies." The Lancet. Diabetes & Endocrinology, vol. 6, no. 6, 2018, p. 464, https://doi.org/10.1016/S2213-8587(18)30071-8.